Market Cap

Diamyd Medical AB Market Capitalization:

kr653.7 Million

SEK as of Jan. 1, 2024

US$64.9 Million

business Diamyd Medical AB Company Profile

Diamyd Medical AB Main Stock Listing

OMX: DMYD.B

Market Capitalization History of Diamyd Medical AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Diamyd Medical AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr653.7 M -46.01%
Jan. 1, 2023 kr1.21 B -9.65%
Jan. 1, 2022 kr1.34 B -36.90%
Jan. 1, 2021 kr2.12 B 46.49%
Jan. 1, 2020 kr1.45 B 141.51%
Jan. 1, 2019 kr600.3 M 98.45%
Jan. 1, 2018 kr302.5 M -28.68%
Jan. 1, 2017 kr424.1 M 33.12%
Jan. 1, 2016 kr318.6 M -0.96%
Jan. 1, 2015 kr321.7 M 30.00%
Jan. 1, 2014 kr247.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Diamyd Medical AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Diamyd Medical AB has the following listings and related stock indices.


Stock: OMX: DMYD.B

Stock: FSX: DMN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.